For research teamsHelp me find a study
Back to all studies
Not Yet RecruitingNCT07396415

Telehealth-Supported Breastfeeding Counseling in Primiparous Mothers

This study is not yet recruiting. It focuses on depression and currently lists study information in Turkey.

Depression, Breastfeeding, ...OtherFrom 18 Years to 45 Years
Need help deciding?

Ask HopeStage to review this study with me

Loading the security check...
Study ID: NCT07396415. We help you review the study, but cannot decide medical eligibility.
In plain English

Key information made simple

This study is looking at whether a digital support tool can help people with Breastfeeding, Postpartum Depression, or Breastfeeding Self-Efficacy. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.

What to expect

Your next step

The official record suggests a mix of remote and in-person participation through a university, with sites including Marmara University Faculty of Medicine in Istanbul. Participation appears to involve questionnaires, interviews, or regular check-ins about day-to-day experience. The main fit is usually being able to understand the study and consent, while common reasons not to take part include pregnancy or breastfeeding and other factors that could make participation unsuitable. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateEstimated: February 25, 2026
Recruitment status
Not Yet Recruiting
Estimated enrollment
Not clearly listed
Sponsor
Marmara University
Sponsor type
University
Study type
Other
Intervention type
Medication / drug
Study phase
Not clearly listed
Locations
Turkey
Age range
From 18 Years to 45 Years
Official registry ID
NCT07396415
Official source
Official registry link

Want help reviewing this study?

Loading the security check...
Study ID: NCT07396415. We help you review the study, but cannot decide medical eligibility.
Why this study may matter

Why this study may matter

This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.

In practice

For you

Taking part may help improve understanding of your condition.

It requires regular follow-up, often through questionnaires or interviews.

Mixes in-person and remote participation.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study. The phase is not clearly listed in the public registry. Phase is mostly relevant for medication studies and some device studies. For this study, it may be more useful to look at what is required, the duration, visits, and eligibility criteria.

Who might this study be for?

This study may concern people with depression; age range: From 18 Years to 45 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by Marmara University, which appears to be a university. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The registry indicates that this study has not started recruiting yet. You can check the planned start date and available contacts.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Other studies you may want to explore next

Telehealth-Supported Breastfeeding Counseling in Primiparous Mothers — Depression Clinical Trial | HopeStage